NCT07817394Not yet recruiting
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
This PMCF study is to obtain patient feedback using online questionnaires. There will be no involvement from healthcare professionals (HCPs) or investigator sites. Up to 100 Patients are being recruited by My Health Focus through their website. The study is performed throughout the UK except Northern Ireland with no sites involved in this study. Patients apply directly to participate in the study and the testing and questionnaire responses are completed at home.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 20 Aug 2026
- Start date
- 21 Sept 2026
- Primary completion date
- 31 Oct 2026
- Lead sponsor
- Dermal Laboratories Ltd
- Diseases
- Psoriasis
- NCT number
- NCT07817394
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 21 Sept 2026 to the primary completion date, 31 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently participating in a study involving an investigational medicinal product/medical device or having participated in the previous 30 days.
Other illness
- Known history of intolerance or skin sensitivity to any of the ingredients of Doublebase Once (as identified on the Patient Information Sheet and product labelling), or similar products used.
Other
- Does not regularly use an emollient
- Patients currently residing in Northern Ireland (this is due to the different approval process)
- Patients (or their parents/legal guardians, in the case of infants, very young children or adolescent adults) who may have difficulties completing the feedback questionnaires, which will be written in English only.
- Employees of My Health Focus or the Sponsor (Dermal or the Diomed group companies), or any immediate family member (partner, offspring, parents, siblings or sibling's offspring) of such employees
Who the study is looking for
- Patients with psoriasis of any severity previously diagnosed by a Healthcare Professional (HCP).
- Patients normally managing their skin condition by regular and ongoing use of leave-on emollient(s).
- Patients willing to incorporate Doublebase Once into their normal skin condition management routine for approximately 1 month as their only emollient and instead of their usual emollient
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.